HEILONGJIANG ZBD PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 603567 for the last quarter is 1.10 B CNY, and it's 31.81% higher compared to the previous quarter. The net income of Q1 24 is 293.37 M CNY.